Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling
- 31 December 2003
- journal article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 38 (3) , 345-367
- https://doi.org/10.1016/j.yrtph.2003.07.004
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment.Environmental Health Perspectives, 2002
- Uncertainty/Safety Factors in Health Risk Assessment: Opportunities for ImprovementHuman and Ecological Risk Assessment: An International Journal, 2001
- A Physiological Toxicokinetic Model for Exogenous and Endogenous Ethylene and Ethylene Oxide in Rat, Mouse, and Human: Formation of 2-Hydroxyethyl Adducts with Hemoglobin and DNAToxicology and Applied Pharmacology, 2000
- Computer Simulation of the Lactational Transfer of Tetrachloroethylene in Rats Using a Physiologically Based ModelToxicology and Applied Pharmacology, 1994
- A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and manArchives of Toxicology, 1994
- Effects of Ranitidine on Blood Alcohol Levels After Ethanol IngestionJAMA, 1992
- Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humansToxicology and Applied Pharmacology, 1991
- Development of a physiologically based pharmacokinetic model for chloroformToxicology and Applied Pharmacology, 1990
- Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicology and Applied Pharmacology, 1987
- Interspecies Scaling of Regional Drug DeliveryJournal of Pharmaceutical Sciences, 1986